Lonza Group AG (OTCMKTS:LZAGY – Get Free Report) was the target of a large growth in short interest in December. As of December 31st, there was short interest totalling 22,500 shares, a growth of 5,525.0% from the December 15th total of 400 shares. Based on an average daily trading volume, of 85,500 shares, the days-to-cover ratio is presently 0.3 days.
Analysts Set New Price Targets
Several analysts have weighed in on the company. Redburn Atlantic upgraded Lonza Group to a “strong-buy” rating in a research report on Wednesday, November 27th. The Goldman Sachs Group raised shares of Lonza Group to a “strong-buy” rating in a report on Wednesday, October 9th.
View Our Latest Research Report on Lonza Group
Lonza Group Price Performance
About Lonza Group
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics, Small Molecules, Cell & Gene, and Capsules & Health Ingredients segments.
Featured Articles
- Five stocks we like better than Lonza Group
- Bank Stocks – Best Bank Stocks to Invest In
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- 3 Monster Growth Stocks to Buy Now
- How Do Stock Buybacks Affect Shareholders?
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Lonza Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lonza Group and related companies with MarketBeat.com's FREE daily email newsletter.